Global Personalized Medicine Biomarkers Market

Table Of Content

Executive Summary
1. Introduction
Market Introduction
1. Market Definition
2. Scope of the Study
3. Market Structure
Research Methodology
1. Primary Research
2. Research Methodology
3. Assumptions & Exclusions
4. Secondary Data Sources
Market Factor Analysis
1. Value Chain Analysis: Personalized Medicine Biomarkers Market
2. Porters Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of Substitution
  4. Threat of New Entrants
  5. Competitive Rivalry
Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
Recent Trends Analysis
Impact of COVID-19 on Personalized Medicine Biomarkers Market
1. Pre and Post Covid -19 Market Scenario Analysis
2. Market Recovery Timeline and Challenge
3. Measures Taken by Top Players
Regulatory Landscape
Personalized Medicine Biomarkers Market, By Type
1. Introduction
  1. Market Size and Forecast, By Type
2. Diagnostic Biomarkers
  1. Market Size and Forecast, By Region
3. Prognostic Biomarkers
  1. Market Size and Forecast, By Region
4. Predictive Biomarkers
  1. Market Size and Forecast, By Region
5. Pharmacodynamic Biomarkers
  1. Market Size and Forecast, By Region
Personalized Medicine Biomarkers Market, By Indication
1. Introduction
  1. Market Size and Forecast, By Indication
2. Oncology
  1. Market Size and Forecast, By Region
3. Neurology
  1. Market Size and Forecast, By Region
4. Diabetes
  1. Market Size and Forecast, By Region
5. Autoimmune Diseases
  1. Market Size and Forecast, By Region
6. Cardiology
  1. Market Size and Forecast, By Region
7. Others
  1. Market Size and Forecast, By Region
Personalized Medicine Biomarkers Market, By Application
1. Introduction
  1. Market Size and Forecast, By Application
2. Early Detection/Screening
  1. Market Size and Forecast, By Region
3. Diagnosis
  1. Market Size and Forecast, By Region
4. Treatment Selection
  1. Market Size and Forecast, By Region
5. Monitoring
  1. Market Size and Forecast, By Region
Regional Overview
1. Introduction
  1. Market Size and Forecast
2. North America
  1. Market Size and Forecast
    1. By Type
      1. Diagnostic Biomarkers
      2. Prognostic Biomarkers
      3. Predictive Biomarkers
      4. Pharmacodynamic Biomarkers
    2. By Indication
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune Diseases
      5. Cardiology
      6. Others
    3. By Application
      1. Early Detection/Screening
      2. Diagnosis
      3. Treatment Selection
      4. Monitoring
  2. U.S.
    1. By Type
      1. Diagnostic Biomarkers
      2. Prognostic Biomarkers
      3. Predictive Biomarkers
      4. Pharmacodynamic Biomarkers
    2. By Indication
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune Diseases
      5. Cardiology
      6. Others
    3. By Application
      1. Early Detection/Screening
      2. Diagnosis
      3. Treatment Selection
      4. Monitoring
  3. Canada
3. Europe
  1. Market Size and Forecast
    1. By Type
      1. Diagnostic Biomarkers
      2. Prognostic Biomarkers
      3. Predictive Biomarkers
      4. Pharmacodynamic Biomarkers
    2. By Indication
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune Diseases
      5. Cardiology
      6. Others
    3. By Application
      1. Early Detection/Screening
      2. Diagnosis
      3. Treatment Selection
      4. Monitoring
  2. U.K.
    1. By Type
      1. Diagnostic Biomarkers
      2. Prognostic Biomarkers
      3. Predictive Biomarkers
      4. Pharmacodynamic Biomarkers
    2. By Indication
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune Diseases
      5. Cardiology
      6. Others
    3. By Application
      1. Early Detection/Screening
      2. Diagnosis
      3. Treatment Selection
      4. Monitoring
  3. Germany
  4. France
  5. Spain
  6. Italy
  7. Russia
  8. Nordic
  9. Benelux
  10. Rest of Europe
4. APAC
  1. Market Size and Forecast
    1. By Type
      1. Diagnostic Biomarkers
      2. Prognostic Biomarkers
      3. Predictive Biomarkers
      4. Pharmacodynamic Biomarkers
    2. By Indication
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune Diseases
      5. Cardiology
      6. Others
    3. By Application
      1. Early Detection/Screening
      2. Diagnosis
      3. Treatment Selection
      4. Monitoring
  2. China
    1. By Type
      1. Diagnostic Biomarkers
      2. Prognostic Biomarkers
      3. Predictive Biomarkers
      4. Pharmacodynamic Biomarkers
    2. By Indication
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune Diseases
      5. Cardiology
      6. Others
    3. By Application
      1. Early Detection/Screening
      2. Diagnosis
      3. Treatment Selection
      4. Monitoring
  3. Korea
  4. Japan
  5. India
  6. Australia
  7. Singapore
  8. Taiwan
  9. South East Asia
  10. Rest of Asia-Pacific
5. Middle East and Africa
  1. Market Size and Forecast
    1. By Type
      1. Diagnostic Biomarkers
      2. Prognostic Biomarkers
      3. Predictive Biomarkers
      4. Pharmacodynamic Biomarkers
    2. By Indication
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune Diseases
      5. Cardiology
      6. Others
    3. By Application
      1. Early Detection/Screening
      2. Diagnosis
      3. Treatment Selection
      4. Monitoring
  2. UAE
    1. By Type
      1. Diagnostic Biomarkers
      2. Prognostic Biomarkers
      3. Predictive Biomarkers
      4. Pharmacodynamic Biomarkers
    2. By Indication
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune Diseases
      5. Cardiology
      6. Others
    3. By Application
      1. Early Detection/Screening
      2. Diagnosis
      3. Treatment Selection
      4. Monitoring
  3. Turky
  4. Saudi Arabia
  5. South Africa
  6. Egypt
  7. Nigeria
  8. Rest of MEA
6. LATAM
  1. Market Size and Forecast
    1. By Type
      1. Diagnostic Biomarkers
      2. Prognostic Biomarkers
      3. Predictive Biomarkers
      4. Pharmacodynamic Biomarkers
    2. By Indication
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune Diseases
      5. Cardiology
      6. Others
    3. By Application
      1. Early Detection/Screening
      2. Diagnosis
      3. Treatment Selection
      4. Monitoring
  2. Brazil
    1. By Type
      1. Diagnostic Biomarkers
      2. Prognostic Biomarkers
      3. Predictive Biomarkers
      4. Pharmacodynamic Biomarkers
    2. By Indication
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune Diseases
      5. Cardiology
      6. Others
    3. By Application
      1. Early Detection/Screening
      2. Diagnosis
      3. Treatment Selection
      4. Monitoring
  3. Mexico
  4. Argentina
  5. Chile
  6. Colombia
  7. Rest of LATAM
Competitive Landscape, 2024
1. Introduction
2. Personalized Medicine Biomarkers Market Share Analysis, 2024 (%)
  1. Market Share Analysis, 2024
  2. Competition Ranking, 2024
  3. Key Developments & Growth Strategies
    1. Merger & Acquisition
    2. Product Launch
    3. Expansion
  4. Consolidated SWOT Analysis of Key Players
Company Profile
1. Thermo Fisher Scientific
  1. Business Overview
  2. Financial Data
  3. Key Product Categories
  4. Recent Developments
2. Illumina
3. Roche Diagnostics
4. Abbott Laboratories
5. Agilent Technologies
6. Qiagen
7. Bio-Rad Laboratories
8. Siemens Healthineers
9. GE Healthcare
10. Foundation Medicine
11. Guardant Health
12. Exact Sciences
13. Myriad Genetics
14. Novartis
15. Merck & Co.

	


A PHP Error was encountered

Severity: Warning
Message:  Undefined array key "list_tbl_fig"
Filename: reports/toc.php
Line Number: 79


	Backtrace:
	
		
	
		
	
		
			
			File: /var/www/html/application/views/frontend/reports/toc.php

			Line: 79

			Function: _error_handler			

		
	
		
	
		
	
		
			
			File: /var/www/html/application/controllers/Web.php

			Line: 215

			Function: view			

		
	
		
	
		
			
			File: /var/www/html/index.php

			Line: 316

			Function: require_once

Check Discount

Get Free Sample

Buy Now

Key Topics Covered

Market Factors (Including Drivers and Restraint)
Market Trends
Market Estimates and Forcasts
Competitive Analysis
Future Market Opportunities

Global Personalized Medicine Biomarkers Market Size, Share & Trends Analysis Report By Type (Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Pharmacodynamic Biomarkers), By Indica. . . . .

Table Of Content

A PHP Error was encountered